BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1452333)

  • 1. Relative abilities of distinct isotypes of human major histocompatibility complex class II molecules to bind streptococcal pyrogenic exotoxin types A and B.
    Imanishi K; Igarashi H; Uchiyama T
    Infect Immun; 1992 Dec; 60(12):5025-9. PubMed ID: 1452333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin.
    Uchiyama T; Saito S; Inoko H; Yan XJ; Imanishi K; Araake M; Igarashi H
    Infect Immun; 1990 Dec; 58(12):3877-82. PubMed ID: 2123824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of murine T cells by streptococcal pyrogenic exotoxin type A. Requirement for MHC class II molecules on accessory cells and identification of V beta elements in T cell receptor of toxin-reactive T cells.
    Imanishi K; Igarashi H; Uchiyama T
    J Immunol; 1990 Nov; 145(10):3170-6. PubMed ID: 2230113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological and biochemical characterization of streptococcal pyrogenic exotoxins I and J (SPE-I and SPE-J) from Streptococcus pyogenes.
    Proft T; Arcus VL; Handley V; Baker EN; Fraser JD
    J Immunol; 2001 Jun; 166(11):6711-9. PubMed ID: 11359827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative ability of distinct isotypes of human major histocompatibility complex class II molecules in binding staphylococcal enterotoxin A.
    Saito S; Imanishi K; Araake M; Yan XJ; Igarashi H; Uchiyama T
    Microbiol Immunol; 1991; 35(8):661-73. PubMed ID: 1753884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.
    Uchiyama T; Imanishi K; Saito S; Araake M; Yan XJ; Fujikawa H; Igarashi H; Kato H; Obata F; Kashiwagi N
    Eur J Immunol; 1989 Oct; 19(10):1803-9. PubMed ID: 2583222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.
    Scholl P; Diez A; Mourad W; Parsonnet J; Geha RS; Chatila T
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4210-4. PubMed ID: 2542966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.
    Scholl PR; Sekaly RP; Diez A; Glimcher LH; Geha RS
    Eur J Immunol; 1990 Sep; 20(9):1911-6. PubMed ID: 2209697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the streptococcal superantigen SPE-C: dimerization and zinc binding suggest a novel mode of interaction with MHC class II molecules.
    Roussel A; Anderson BF; Baker HM; Fraser JD; Baker EN
    Nat Struct Biol; 1997 Aug; 4(8):635-43. PubMed ID: 9253413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The superantigen streptococcal pyrogenic exotoxin C (SPE-C) exhibits a novel mode of action.
    Li PL; Tiedemann RE; Moffat SL; Fraser JD
    J Exp Med; 1997 Aug; 186(3):375-83. PubMed ID: 9236189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two novel superantigens found in both group A and group C Streptococcus.
    Proft T; Webb PD; Handley V; Fraser JD
    Infect Immun; 2003 Mar; 71(3):1361-9. PubMed ID: 12595453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules.
    Scholl PR; Diez A; Karr R; Sekaly RP; Trowsdale J; Geha RS
    J Immunol; 1990 Jan; 144(1):226-30. PubMed ID: 2404064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles.
    Norrby-Teglund A; Nepom GT; Kotb M
    Eur J Immunol; 2002 Sep; 32(9):2570-7. PubMed ID: 12207341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex class II binding site for streptococcal pyrogenic (erythrogenic) toxin A.
    Hartwig UF; Gerlach D; Fleischer B
    Med Microbiol Immunol; 1994 Nov; 183(5):257-64. PubMed ID: 7715537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
    Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
    J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of novel superantigens from Streptococcus pyogenes.
    Proft T; Moffatt SL; Berkahn CJ; Fraser JD
    J Exp Med; 1999 Jan; 189(1):89-102. PubMed ID: 9874566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor production by human T-cells stimulated with bacterial superantigens.
    Imanishi K; Inada K; Akatsuka H; Gu Y; Igarashi H; Uchiyama T
    Int J Immunopharmacol; 1995 Oct; 17(10):841-8. PubMed ID: 8707449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallographic and mutational data show that the streptococcal pyrogenic exotoxin J can use a common binding surface for T-cell receptor binding and dimerization.
    Baker HM; Proft T; Webb PD; Arcus VL; Fraser JD; Baker EN
    J Biol Chem; 2004 Sep; 279(37):38571-6. PubMed ID: 15247241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).
    Norrby-Teglund A; Newton D; Kotb M; Holm SE; Norgren M
    Infect Immun; 1994 Dec; 62(12):5227-33. PubMed ID: 7960098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome.
    Roggiani M; Stoehr JA; Olmsted SB; Matsuka YV; Pillai S; Ohlendorf DH; Schlievert PM
    Infect Immun; 2000 Sep; 68(9):5011-7. PubMed ID: 10948118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.